Jihad Al Hassan, Georges Yared, Charlotte El Hajjar, Manal Dahrouj, Christopher Massaad, Ahmad El Moghrabi, Kariman Ghazal
{"title":"Non-immune hydrops fetalis (NIHF): diagnostic evaluation and lessons learned from a case series.","authors":"Jihad Al Hassan, Georges Yared, Charlotte El Hajjar, Manal Dahrouj, Christopher Massaad, Ahmad El Moghrabi, Kariman Ghazal","doi":"10.1080/20565623.2026.2681420","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Fetal hydrops, characterized by abnormal fluid accumulation in two or more fetal compartments, is a critical condition with a poor prognosis, often resulting in significant fetal mortality. The condition itself is not a diagnosis but a clinical sign with many underlying causes, ranging from infections and chromosomal abnormalities to rare maternal conditions such as mirror syndrome.</p><p><strong>Case presentation: </strong>This review examines three cases of fetal hydrops, highlighting common etiologies, such as infections and chromosomal disorders, and more unusual causes like maternal complications.</p><p><strong>Diagnostic approach: </strong>The current approach to diagnosing hydrops fetalis relies primarily on ultrasound imaging and Doppler studies to identify abnormal fluid accumulation and pathophysiology.</p><p><strong>Future perspective: </strong>However, advances in genomic testing are rapidly transforming the diagnostic pathway. With increasing accuracy, speed and accessibility of genetic testing, it is likely that these tools will be integrated earlier in the diagnostic process, potentially improving prognostic assessments and treatment outcomes.</p><p><strong>Conclusion: </strong>The importance of early and accurate identification of the cause is essential to inform clinical management, improve fetal survival rates and support parental decision-making.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"12 1","pages":"2681420"},"PeriodicalIF":2.5000,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13240947/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Science OA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/20565623.2026.2681420","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/3 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Fetal hydrops, characterized by abnormal fluid accumulation in two or more fetal compartments, is a critical condition with a poor prognosis, often resulting in significant fetal mortality. The condition itself is not a diagnosis but a clinical sign with many underlying causes, ranging from infections and chromosomal abnormalities to rare maternal conditions such as mirror syndrome.
Case presentation: This review examines three cases of fetal hydrops, highlighting common etiologies, such as infections and chromosomal disorders, and more unusual causes like maternal complications.
Diagnostic approach: The current approach to diagnosing hydrops fetalis relies primarily on ultrasound imaging and Doppler studies to identify abnormal fluid accumulation and pathophysiology.
Future perspective: However, advances in genomic testing are rapidly transforming the diagnostic pathway. With increasing accuracy, speed and accessibility of genetic testing, it is likely that these tools will be integrated earlier in the diagnostic process, potentially improving prognostic assessments and treatment outcomes.
Conclusion: The importance of early and accurate identification of the cause is essential to inform clinical management, improve fetal survival rates and support parental decision-making.
期刊介绍:
Future Science OA is an online, open access, peer-reviewed title from the Future Science Group. The journal covers research and discussion related to advances in biotechnology, medicine and health. The journal embraces the importance of publishing all good-quality research with the potential to further the progress of research in these fields. All original research articles will be considered that are within the journal''s scope, and have been conducted with scientific rigour and research integrity. The journal also features review articles, editorials and perspectives, providing readers with a leading source of commentary and analysis. Submissions of the following article types will be considered: -Research articles -Preliminary communications -Short communications -Methodologies -Trial design articles -Trial results (including early-phase and negative studies) -Reviews -Perspectives -Commentaries